Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Health Law and Policy (45)
- Agriculture Law (23)
- Law and Society (23)
- Environmental Law (21)
- International Law (20)
-
- Intellectual Property Law (18)
- Constitutional Law (17)
- Administrative Law (15)
- Human Rights Law (13)
- International Trade Law (13)
- Litigation (13)
- Natural Resources Law (13)
- State and Local Government Law (13)
- Energy and Utilities Law (12)
- Land Use Law (12)
- Public Law and Legal Theory (12)
- Science and Technology Law (12)
- Law of the Sea (11)
- Oil, Gas, and Mineral Law (11)
- Water Law (11)
- Legislation (10)
- Criminal Law (9)
- Social and Behavioral Sciences (9)
- Consumer Protection Law (7)
- Commercial Law (5)
- First Amendment (5)
- Medical Jurisprudence (5)
- Medicine and Health Sciences (5)
- Institution
-
- University of Arkansas, Fayetteville (20)
- American University Washington College of Law (14)
- Pace University (9)
- University of Michigan Law School (9)
- Georgia State University College of Law (6)
-
- Yeshiva University, Cardozo School of Law (5)
- Boston University School of Law (4)
- Brooklyn Law School (4)
- Seattle University School of Law (4)
- Mitchell Hamline School of Law (3)
- Northwestern Pritzker School of Law (3)
- University of Missouri School of Law (3)
- Vanderbilt University Law School (3)
- Washington and Lee University School of Law (3)
- California Western School of Law (2)
- Columbia Law School (2)
- Florida International University College of Law (2)
- Loyola University Chicago, School of Law (2)
- Roger Williams University (2)
- St. John's University School of Law (2)
- Texas A&M University School of Law (2)
- University of Georgia School of Law (2)
- University of South Carolina (2)
- University of Washington School of Law (2)
- William & Mary Law School (2)
- Chicago-Kent College of Law (1)
- Cleveland State University (1)
- DePaul University (1)
- Embry-Riddle Aeronautical University (1)
- Emory University School of Law (1)
- Keyword
-
- Drugs (13)
- Food policy (10)
- FDA (9)
- Food (9)
- Food regulation (9)
-
- Pharmaceuticals (8)
- Food and Drug Administration (7)
- Regulation (7)
- Agriculture (6)
- Food law (6)
- Public health (6)
- Controlled Substances Act (5)
- Farm Bill (4)
- Farmers (4)
- First Amendment (4)
- Generic drugs (4)
- Law (4)
- Medicine (4)
- Patents (4)
- Pharmaceutical (4)
- USDA (4)
- BSA (3)
- Bank Secrecy Act (3)
- Biologics (3)
- CSA (3)
- Climate change (3)
- Drug policy (3)
- Drug promotion (3)
- FDCA (3)
- Food security (3)
- Publication
-
- Journal of Food Law & Policy (19)
- Sustainable Development Law & Policy (11)
- Faculty Scholarship (9)
- Faculty Publications (8)
- Elisabeth Haub School of Law Faculty Publications (6)
-
- Georgia State University Law Review (5)
- Articles (4)
- Seattle University Law Review (4)
- Cardozo Law Review (3)
- Washington and Lee Law Review (3)
- American University Law Review (2)
- Cardozo Journal of Conflict Resolution (2)
- Columbia Center on Sustainable Investment Staff Publications (2)
- Cybaris® (2)
- Faculty Publications & Other Works (2)
- Georgia Journal of International & Comparative Law (2)
- Michigan Journal of Environmental & Administrative Law (2)
- Michigan Law Review (2)
- Northwestern Journal of Law & Social Policy (2)
- Pace Environmental Law Review (2)
- St. John's Law Review (2)
- Vanderbilt Journal of Transnational Law (2)
- Arkansas Law Review (1)
- Brooklyn Journal of International Law (1)
- Brooklyn Law Review (1)
- Buffalo Law Review (1)
- Catholic University Journal of Law and Technology (1)
- Chicago-Kent Law Review (1)
- DePaul Business & Commercial Law Journal (1)
- Faculty Articles (1)
- Publication Type
Articles 91 - 120 of 133
Full-Text Articles in Food and Drug Law
Localism, Labels, And Animal Welfare, Samuel R. Wiseman
Localism, Labels, And Animal Welfare, Samuel R. Wiseman
Northwestern Journal of Law & Social Policy
The law does relatively little to improve the welfare of animals raised for food. In the short term, at least, market-based solutions appear to have more promise as a means of promoting farm animal welfare, as consumers increasingly seek out local and humanely-raised meat and eggs. To aid consumers in identifying these products, certification systems of varying degrees of rigor exist, but even these are of little use to consumers in the restaurant context, which accounts for a large percentage of meat consumption. Patrons see only finished meals, making fraud difficult to detect, and a recent newspaper investigation suggests that …
Rethinking The Dormant Commerce Clause?: Climate Change And Food Security, Michael Barsa
Rethinking The Dormant Commerce Clause?: Climate Change And Food Security, Michael Barsa
Northwestern Journal of Law & Social Policy
No abstract provided.
Localism, Labels And Animal Welfare, Samuel R. Wiseman
Localism, Labels And Animal Welfare, Samuel R. Wiseman
Scholarly Publications
The law does relatively little to improve the welfare of animals raised for food. In the short term, at least, market-based solutions appear to have more promise as a means of promoting farm animal welfare, as consumers increasingly seek out local and humanelyraised meat and eggs. To aid consumers in identifying these products, certification systems of varying degrees of rigor exist, but even these are of little use to consumers in the restaurant context, which accounts for a large percentage of meat consumption. Patrons see only finished meals, making fraud difficult to detect, and a recent newspaper investigation suggests that …
Privacy Of Information And Dna Testing Kits, Shanna Raye Mason
Privacy Of Information And Dna Testing Kits, Shanna Raye Mason
Catholic University Journal of Law and Technology
In modern times, consumers desire for more control over their own health and healthcare. With this growing interest of control, direct to consumer DNA testing kits have never been more popular. However, many consumers are unaware of the potential privacy concerns associated with such use. This comment examines the popularity and privacy risks that are likely unknown to the individual consumer. This comment also addresses the shortcomings of the Health Insurance Portability and Accountability Act of 1996 (HIPAA), as well as the Genetic Information Nondiscrimination Act of 2008 (GINA) in regard to protecting individual’s genetic information from misuse. This comment …
What Motivates Legislators To Act: Problem Definition & The Opioid Epidemic, A Case Study, Taleed El-Sabawi
What Motivates Legislators To Act: Problem Definition & The Opioid Epidemic, A Case Study, Taleed El-Sabawi
Faculty Publications
This article explores why federal legislators may have been motivated to treat the current opioid crisis as a health issue, when past drug problems have been treated as a criminal justice issue. Using theories from political science, policy studies and sociology, this article summarizes leading theories of legislative behavior and applies them to the current opioid crisis, in an effort to better understand what motivates legislators to enact legislation to solve pressing social problems in a way that reframes the problem. Part II of this article provides an overview of the Comprehensive Addiction and Recovery Act, its significance, and how …
Defining The Opioid Epidemic: Congress, Pressure Groups, And Problem Definition, Taleed El-Sabawi
Defining The Opioid Epidemic: Congress, Pressure Groups, And Problem Definition, Taleed El-Sabawi
Faculty Publications
The passage of the Comprehensive Addiction and Recovery Act of 2016 evidences a shift in federal legislative support from criminal justice oriented legislative alternatives to more health oriented legislative alternatives to addressing the ongoing Opioid Epidemic. Such a shift was preceded by a redefinition of problem drug use in the policy discourse from an issue of deviancy to a health issue. However, the redefinition of problem drug use as a health issue, has been dominated by policy narratives and causal stories that do not define problem drug use in a manner that aligns with a multi-modal public health oriented legislative …
Beyond Corporate Form: A Response To Dan Depasquale, Surbhi Sarang, And Natalie Bump Vena’S Forging Food Justice Through Cooperatives In New York City, Jonathan Brown
Elisabeth Haub School of Law Faculty Publications
In their article, Forging Food Justice Through Cooperatives in New York City, Dan DePasquale, Surbhi Sarang, and Natalie Bump Vena (the “Authors”) argue that consumer-owned and worker-owned cooperatives hold promise as a means for advancing policy objectives associated with “food justice,” namely building community wealth and power and providing more affordable access to healthy food in low-income and minority communities. Looking to examples of legislation and policies in other jurisdictions, they advocate for a wide range of policies to promote the viability of cooperatives in New York City, including reforms to cooperative corporation laws and strategies for better allocating funding …
Crafting Next Generation Eco-Label Policy, Jason J. Czarnezki, Katrina F. Kuh
Crafting Next Generation Eco-Label Policy, Jason J. Czarnezki, Katrina F. Kuh
Elisabeth Haub School of Law Faculty Publications
Eco-labels present a promising policy tool in the effort to achieve sustainable consumption. Many questions remain, however, about the extent to which eco-labels can contribute to sustainability efforts and how to maximize their effectiveness. This Article deploys research from evolutionary psychology, behavioral law and economics, and norm theory to offer specific insights for the design and implementation of eco-labels to enhance their influence on sustainable consumer choice. Notably, this research suggests possibilities for eco-labels to shape or expand consumer preferences for green goods, and thereby enhance eco-label influence on consumer behavior by extending it beyond eco-minded consumers. We suggest that …
Serving Up Allergy Labeling: Mitigating Food Allergen Risks In Restaurants, Marie C. Boyd
Serving Up Allergy Labeling: Mitigating Food Allergen Risks In Restaurants, Marie C. Boyd
Faculty Publications
Allergens in restaurant food cause many allergic reactions and deaths. Yet no federal, state, or local law adequately protects people from these harms. Although federal law requires the labeling of “major food allergens” in packaged food, there are no allergen labeling requirements for restaurant-type food. In addition, existing food safety requirements for restaurants are inadequate to prevent allergen cross contact.
The existing legal scholarship on food allergens in restaurants is limited. Much of the legal scholarship on labeling in restaurants focuses on menu labeling — the provision of calorie and other nutrition information to combat obesity. The requirements of Section …
“High” Standards: How The Tide Of Marijuana Legalization Sweeping The Country Ignores The Hidden Risks Of Edibles, Steve Calandrillo, Katelyn Fulton
“High” Standards: How The Tide Of Marijuana Legalization Sweeping The Country Ignores The Hidden Risks Of Edibles, Steve Calandrillo, Katelyn Fulton
Articles
As a tide of marijuana legalization sweeps across the United States, there is a surprising lack of scrutiny as to whether the benefits of recreational marijuana outweigh the risks. Notably, marijuana edibles present special risks to the population that are not present in smoked marijuana. States that have legalized recreational marijuana are seeing an increase in edible-related calls to poison control centers and visits to emergency rooms. These negative reactions are especially prevalent in vulnerable populations such as children, persons with underlying preexisting conditions, and out-of-state marijuana novices. Unfortunately, research on edible marijuana is scant and state regulatory regimes are …
A Solution In Search Of A Problem At The Biologics Frontier, Erika Lietzan
A Solution In Search Of A Problem At The Biologics Frontier, Erika Lietzan
Faculty Publications
This short paper comments on Professor Carrier's new article, Biologics: The New Antitrust Frontier. His article makes a profound initial contribution to a new area of scholarship, based on a large body of prior work considering antitrust issues relating to small molecule drugs. But Professor Carrier’s article, like my own forthcoming piece on innovation and competition in the biologics marketplace, is inherently speculative. We are making our best judgments about the nature of a still emerging marketplace and likely conduct in that marketplace, based on our understandings of a new regulatory framework that is itself still emerging, the broader legal …
The Opioid Epidemic And Rural American: Why The Usda Should Lead The Response, Lexy Gross
The Opioid Epidemic And Rural American: Why The Usda Should Lead The Response, Lexy Gross
Kentucky Journal of Equine, Agriculture, & Natural Resources Law
No abstract provided.
The Off-Label Use Of Pom Wonderful: Using Section 43(A) To Eliminate Misleading Off-Label Drug Promotion, Christopher A. Hurley
The Off-Label Use Of Pom Wonderful: Using Section 43(A) To Eliminate Misleading Off-Label Drug Promotion, Christopher A. Hurley
Washington and Lee Law Review
No abstract provided.
Delaying Competition: How Sound Public Policy And Rigorous Antitrust Scrutiny Can Be Applied To Controversial Patent Settlements, 17 J. Marshall Rev. Intell. Prop. L. 655 (2018), Sam Hensel
UIC Review of Intellectual Property Law
The rising costs of prescription drugs are a growing concern for many Americans. The restraint of trade for pharmaceutical drugs is a cause of rising costs for consumers, as companies seek to push potential competitors out of the market to maintain profits. This unlawful restraint of trade will be discussed in this comment. Specifically, this comment will focus on "Pay for Delay" agreements, mostly between generic versus brand name pharmaceutical manufacturers. The proliferation of these agreements only leads to an unsustainable market that discourages innovation and advancement, and promotes fraud, as invalid patents are used as leverage to prevent generics …
The Demise Of Drug Design Litigation; Death By Federal Preemption, Aaron D. Twerski
The Demise Of Drug Design Litigation; Death By Federal Preemption, Aaron D. Twerski
American University Law Review
No abstract provided.
Using The Public Nuisance Doctrine To Combat Antibiotic Resistance, Amanda Purcell
Using The Public Nuisance Doctrine To Combat Antibiotic Resistance, Amanda Purcell
American University Law Review
No abstract provided.
Telemedicine Is The New Narcotics Candy Store: Teladoc Opens The Floodgates For The Unrestricted Sale Of Dangerous Drugs, Madeleine Rosuck
Telemedicine Is The New Narcotics Candy Store: Teladoc Opens The Floodgates For The Unrestricted Sale Of Dangerous Drugs, Madeleine Rosuck
SMU Science and Technology Law Review
No abstract provided.
Implementing A Public Health Perspective In Fda Drug Regulation, Patricia J. Zettler, Margaret Foster Riley, Aaron S. Kesselheim
Implementing A Public Health Perspective In Fda Drug Regulation, Patricia J. Zettler, Margaret Foster Riley, Aaron S. Kesselheim
Faculty Publications By Year
There is, without question, a public health crisis in the United States arising from both illicit and prescription opioid misuse, addiction, and overdose. The Food and Drug Administration (FDA) is one regulator with an important role to play in minimizing the harms associated with prescription opioids, while also ensuring that prescription opioids are available for the evidence-based management of pain. One question, however, is to what extent the agency can consider in its decisions to approve opioids and keep existing ones on the market the provider and patient behaviors contributing to the epidemic. This is, in part, because FDA’s approval …
The United States, Mexico, And The War On Drugs In The Trump Administration, James M. Cooper
The United States, Mexico, And The War On Drugs In The Trump Administration, James M. Cooper
Faculty Scholarship
This Article examines the war on drugs as persecuted by the United States and how it has been exported to Mexico. It also explores the increased efforts in the drugs war that the Trump administration, through the U.S. Department of Justice, is pursuing at a domestic level. Part I of this Article provides an outline of the dynamics in the quickly evolving and highly tense relationship between the United States and Mexico. Part II of this Article details the historical background of the U.S.-Mexico border region and demonstrates that the border has long been a contested site. Part III provides …
Consolidation And Innovation In The Pharmaceutical Industry: The Role Of Mergers And Acquisitions In The Current Innovation Ecosystem, Joanna Shepherd
Consolidation And Innovation In The Pharmaceutical Industry: The Role Of Mergers And Acquisitions In The Current Innovation Ecosystem, Joanna Shepherd
Faculty Articles
Recent changes in the pharmaceutical industry have spurred an unprecedented wave of mergers and acquisitions. Some researchers and agencies have questioned whether pharmaceutical consolidation could impede drug innovation. However, as I explain in this Article, these concerns are largely based on an outdated understanding of the drug innovation ecosystem. Whereas a few decades ago almost all drug discovery took place inside traditional pharmaceutical companies, today most drug innovation is externally-sourced from biotech companies and smaller firms. Internal R&D is no longer the primary source, or even an important source, of drug innovation. As a result, analyses that focus on the …
The Fda's Priority Review Voucher Program's Role In Bringing Benznidazle To Chagas Disease Patients In The United States, Lisa Cline
Cybaris®
No abstract provided.
Gender, Race & The Inadequate Regulation Of Cosmetics, Marie C. Boyd
Gender, Race & The Inadequate Regulation Of Cosmetics, Marie C. Boyd
Faculty Publications
Scholars and other commentators have identified failures in the regulation of cosmetics-which depends heavily on voluntary industry self- regulation-and called for more stringent regulation of these products. Yet these calls have largely neglected an important dimension of the problem: the current laissez-faire approach to the regulation of cosmetics disproportionally places women, and particularly women who are members of other excluded groups, at risk. This Article examines federal cosmetics law and regulation through a feminist lens. It argues that cosmetics law and regulation have lagged behind that of the other major product categories regulated by the Food and Drug Administration under …
Regulatory Silence At The Fda, Jordan Paradise
Regulatory Silence At The Fda, Jordan Paradise
Faculty Publications & Other Works
No abstract provided.
Exploring Precision Fda, An Online Platform For Crowdsourcing Genomics, Jordan Paradise
Exploring Precision Fda, An Online Platform For Crowdsourcing Genomics, Jordan Paradise
Faculty Publications & Other Works
The U.S. Food and Drug Administration has created an online platform for the next generation sequencing community, enabling users to evaluate biomarker information and share resources. This article examines this online platform and offers several observations about potential legal and regulatory implications.
Drug Pricing—The Next Compliance Waterloo, Seth Whitelaw, Nicodemo Fiorentino, Jennifer O'Leary
Drug Pricing—The Next Compliance Waterloo, Seth Whitelaw, Nicodemo Fiorentino, Jennifer O'Leary
Mitchell Hamline Law Review
No abstract provided.
The Formulary Fix Buries Fritz & Harvey: Drug Promotion Escapes Its Past Constraints, James T. O'Reilly
The Formulary Fix Buries Fritz & Harvey: Drug Promotion Escapes Its Past Constraints, James T. O'Reilly
Washington and Lee Law Review
No abstract provided.
Reconciling The Lanham Act And The Fdca: A Comment On Chris Hurley’S Note, Christopher B. Seaman
Reconciling The Lanham Act And The Fdca: A Comment On Chris Hurley’S Note, Christopher B. Seaman
Washington and Lee Law Review
No abstract provided.
What Is Useful And Novel? The Collision Between Intellectual Property Protection And Regulation Regarding Medical Devices, James Sutherland
What Is Useful And Novel? The Collision Between Intellectual Property Protection And Regulation Regarding Medical Devices, James Sutherland
Cybaris®
No abstract provided.
Dying For A Solution: The Regulation Of Medical Devices Falls Short In The 21st Century Cures Act, Marilyn Uzdavines
Dying For A Solution: The Regulation Of Medical Devices Falls Short In The 21st Century Cures Act, Marilyn Uzdavines
Nevada Law Journal
No abstract provided.
Scientific Trials--In The Laboratories, Not The Courts, Nicholas Bagley, Aaron E. Carroll, Pieter A. Cohen
Scientific Trials--In The Laboratories, Not The Courts, Nicholas Bagley, Aaron E. Carroll, Pieter A. Cohen
Articles
In 2015, one of us published a peer-reviewed study, together with colleagues at the University of California, San Francisco, replicating prior research from the US Food and Drug Administration (FDA) detecting a designer stimulant, β-methylphenylethylamine, in sports, weight loss, and “cognitive function” supplements sold in the United States. The confirmatory study prompted the FDA to take enforcement action against companies selling the stimulant as a dietary ingredient. One of the companies that received an FDA warning letter sued the study’s authors for $200 million in damages for libel, claiming, without supporting scientific evidence, that multiple statements in the article were …